NEW YORK, May 31 (GenomeWeb News) - The US National Institutes of Health has chosen Fisher Biosciences' Pierce Biotechnology unit to be its 'preferred vendor' for conducting protein sample analysis, Fisher said today.
The NIH will use Pierce's SearchLight multiplex-profiling technology to analyze secreted protein expression in samples submitted by the NIH, including the National Cancer Institute, the National Institute of Allergies and Infectious Diseases and other affiliated NIH organizations, according to Fisher.
SearchLight is a multiplex sandwich enzyme-linked immunosorbent assay in a 96-well plate-based array format. Fisher claims it can measure up to 12 secreted proteins simultaneously per well.
Financial details of the arrangement were not discussed.